Bill would move ALS therapy law dates from 2026 to 2031
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 · Sponsor: Mike Quigley (D-IL) · 103 cosponsors
The measure would move two dates from 2026 to 2031, add ALS grant review and safety steps, and require an FDA action plan.
Government & Ethics · Healthcare